Insider Buy/Sell Details for the Biotechnology Industry — May 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1194)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
680
Price
$597.47
Total Value
$406.28K
Shares Held After
41,093
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$596.05
Total Value
$333.79K
Shares Held After
41,773
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,513
Price
$595.02
Total Value
$900.27K
Shares Held After
42,333
% of Holdings
3.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
346
Price
$594.09
Total Value
$205.55K
Shares Held After
43,846
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$592.26
Total Value
$47.38K
Shares Held After
44,192
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
101
Price
$591.60
Total Value
$59.75K
Shares Held After
44,272
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
320
Price
$590.36
Total Value
$188.92K
Shares Held After
44,373
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
410
Price
$589.18
Total Value
$241.56K
Shares Held After
44,693
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
470
Price
$588.19
Total Value
$276.45K
Shares Held After
45,103
% of Holdings
1.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
805
Price
$586.78
Total Value
$472.36K
Shares Held After
45,573
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
927
Price
$585.53
Total Value
$542.79K
Shares Held After
46,378
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
873
Price
$584.64
Total Value
$510.39K
Shares Held After
47,305
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
796
Price
$583.73
Total Value
$464.65K
Shares Held After
48,178
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
159
Price
$582.73
Total Value
$92.65K
Shares Held After
48,974
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
296
Price
$581.28
Total Value
$172.06K
Shares Held After
49,133
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
384
Price
$580.07
Total Value
$222.75K
Shares Held After
49,429
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$579.12
Total Value
$69.49K
Shares Held After
49,813
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$576.32
Total Value
$46.11K
Shares Held After
49,933
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Setia Vishwas — Chief Financial Officer
Shares
2,068
Price
$29.07
Total Value
$60.12K
Shares Held After
356,256
% of Holdings
0.6%
MapLight Therapeutics, Inc. (MPLT)
Setia Vishwas — Chief Financial Officer
Shares
8,496
Price
$28.04
Total Value
$238.23K
Shares Held After
358,324
% of Holdings
2.3%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
16,421
Price
$29.13
Total Value
$478.34K
Shares Held After
243,450
% of Holdings
6.3%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
15,900
Price
$29.13
Total Value
$463.17K
Shares Held After
350,497
% of Holdings
4.3%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
8,390
Price
$28.04
Total Value
$235.26K
Shares Held After
259,871
% of Holdings
3.1%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
8,152
Price
$28.04
Total Value
$228.58K
Shares Held After
366,397
% of Holdings
2.2%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
15,603
Price
$29.13
Total Value
$454.52K
Shares Held After
1,580,820
% of Holdings
1.0%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
8,098
Price
$28.04
Total Value
$227.07K
Shares Held After
1,596,423
% of Holdings
0.5%
Travere Therapeutics, Inc. (TVTX)
Inrig Jula — CHIEF MEDICAL OFFICER
Shares
311
Price
$43.95
Total Value
$13.67K
Shares Held After
113,238
% of Holdings
0.3%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
22,500
Price
$43.95
Total Value
$988.88K
Shares Held After
432,886
% of Holdings
4.9%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
2,076
Price
$43.95
Total Value
$91.24K
Shares Held After
105,211
% of Holdings
1.9%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
310
Price
$43.95
Total Value
$13.62K
Shares Held After
118,658
% of Holdings
0.3%
Travere Therapeutics, Inc. (TVTX)
ROTE WILLIAM E. — Chief Research Officer
Shares
2,763
Price
$43.95
Total Value
$121.43K
Shares Held After
115,474
% of Holdings
2.3%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
17,244
Price
$18.18
Total Value
$313.50K
Shares Held After
1,136,810
% of Holdings
1.5%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
428
Price
$18.18
Total Value
$7.78K
Shares Held After
7,962
% of Holdings
5.1%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
43,621
Price
$18.18
Total Value
$793.03K
Shares Held After
4,883,494
% of Holdings
0.9%
Dyne Therapeutics, Inc. (DYN)
Rhodes Jason P — Director
Shares
21,926
Price
$18.18
Total Value
$398.61K
Shares Held After
1,549,288
% of Holdings
1.4%
GYRE THERAPEUTICS, INC. (GYRE)
Luo Ying — Director
Shares
179
Price
$8.01
Total Value
$1.43K
Shares Held After
2,575,362
% of Holdings
0.0%
Liquidia Corp (LQDA)
JEFFS ROGER — Director
Shares
25,000
Price
$40.10
Total Value
$1.00M
Shares Held After
1,398,095
% of Holdings
1.8%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
6,860
Price
$0.69
Total Value
$4.73K
Shares Held After
1,672,470
% of Holdings
0.4%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
129
Price
$1.70
Total Value
$219.30
Shares Held After
829
% of Holdings
15.6%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
1,679
Price
$16.00
Total Value
$26.86K
Shares Held After
3,622
% of Holdings
31.7%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Borgeson Blake — Director
Shares
30,000
Price
$3.52
Total Value
$105.60K
Shares Held After
6,199,863
% of Holdings
0.5%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
20,000
Price
$51.83
Total Value
$1.04M
Shares Held After
2,231
% of Holdings
90.0%
Rallybio Corp (RLYB)
ADAR1 Capital Management, LLC — 10% Owner
Shares
35,101
Price
$14.00
Total Value
$491.26K
Shares Held After
779,784
% of Holdings
4.5%
MapLight Therapeutics, Inc. (MPLT)
Setia Vishwas — Chief Financial Officer
Shares
968
Price
$29.00
Total Value
$28.07K
Shares Held After
366,820
% of Holdings
0.3%
MapLight Therapeutics, Inc. (MPLT)
Setia Vishwas — Chief Financial Officer
Shares
9,935
Price
$28.12
Total Value
$279.37K
Shares Held After
367,788
% of Holdings
2.6%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
963
Price
$29.00
Total Value
$27.93K
Shares Held After
268,261
% of Holdings
0.4%
MapLight Therapeutics, Inc. (MPLT)
Lillie James Woodruff — Chief Scientific Officer
Shares
10,132
Price
$28.12
Total Value
$284.91K
Shares Held After
269,224
% of Holdings
3.6%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
931
Price
$29.00
Total Value
$27.00K
Shares Held After
374,549
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Foff Erin Pennock — Chief Medical Officer
Shares
9,645
Price
$28.12
Total Value
$271.22K
Shares Held After
375,480
% of Holdings
2.5%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
928
Price
$29.00
Total Value
$26.91K
Shares Held After
1,604,521
% of Holdings
0.1%
Showing 651–700 of 1194 transactions (page 14 of 24)